A unique feature of this study was determination of mutation status in samples heterozygous for p53 Pro72Arg polymorphism, which enabled us to conclude that Pro72 allele was indeed preferentially mutated in ESCC. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.